Patents by Inventor Jin Jen
Jin Jen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11968206Abstract: A mechanism for building decentralized computer applications that execute on a distributed computing system. The present technology works within a web browser, client application, or other software and provides access to decentralized computer applications through the browser. The present technology is non-custodial, wherein a public-private key pair, which represents user identity, is created on a client machine and then directly encrypted by a third-party platform without relying on one centralized computing system.Type: GrantFiled: September 15, 2023Date of Patent: April 23, 2024Assignee: Magic Labs, Inc.Inventors: Fei-Yang Jen, Yi Wei Chen, Jaemin Jin, Hanyu Xue, Wentao Liu, Shang Li
-
Patent number: 8067240Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.Type: GrantFiled: November 22, 2010Date of Patent: November 29, 2011Assignees: Esoterix Genetic Laboratories, LLC, Johns Hopkins University School of MedicineInventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
-
Publication number: 20110091892Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.Type: ApplicationFiled: November 22, 2010Publication date: April 21, 2011Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
-
Patent number: 7846667Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.Type: GrantFiled: August 20, 2009Date of Patent: December 7, 2010Assignees: Genzyme Corporation, Johns Hopkins UniversityInventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
-
Patent number: 7709202Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.Type: GrantFiled: July 27, 2007Date of Patent: May 4, 2010Assignees: The Johns Hopkins University, Genzyne Corporation, The U.S.A. as represented by the Secretary of the HHSInventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen L Madden, Jin Jen
-
Publication number: 20100100919Abstract: In a method of reducing and diagnosing upstream ingress noise in cable data system utilize a MAC/MAP management messages via a downstream path based on Cable Systems Interface Specification (DOCSIS) to provide precise control of gates deployed near the user side provide a powerful algorithm for CATV operators to mitigate ingress noise problem.Type: ApplicationFiled: December 18, 2009Publication date: April 22, 2010Inventors: Jin-Jen Hsue, Wei-Chih Lu
-
Publication number: 20100062443Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.Type: ApplicationFiled: August 20, 2009Publication date: March 11, 2010Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
-
Patent number: 7639494Abstract: An electronic apparatus includes a first machine assembly, a second machine assembly having a pushing part and a first locking part, and a connection mechanism. The connection mechanism connecting the first and the second machine assemblies includes a body, a driven element having a second locking part and a third locking part, and a fourth locking part disposed on the body. Two ends of the body are pivoted to the first assembly and the second assembly respectively. The driven element is movably disposed on the body. When the second assembly is at a first position and the connection mechanism is at a second position, the second assembly is located above the first assembly, the pushing part and the first locking part are far from the connection mechanism, and the fourth locking part locks the third locking part to restrict the relative movement between the driven element and the body.Type: GrantFiled: January 29, 2008Date of Patent: December 29, 2009Assignee: Inventec CorporationInventor: Jin-Jen Lin
-
Publication number: 20090270265Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.Type: ApplicationFiled: July 27, 2007Publication date: October 29, 2009Applicants: The United States of America as Represented by the Secretary of Health and Human Services, Genzyme Corporation, The Johns Hopkins University School of MedicineInventors: Mariana NACHT, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
-
Publication number: 20090124795Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.Type: ApplicationFiled: April 10, 2008Publication date: May 14, 2009Applicant: JOHNS HOPKINS UNIVERSITYInventors: Makiko Fliss, David Sidransky, Jin Jen, Kornelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
-
Publication number: 20090050027Abstract: An electronic apparatus includes a first machine assembly, a second machine assembly having a pushing part and a first locking part, and a connection mechanism. The connection mechanism connecting the first and the second machine assemblies includes a body, a driven element having a second locking part and a third locking part, and a fourth locking part disposed on the body. Two ends of the body are pivoted to the first assembly and the second assembly respectively. The driven element is movably disposed on the body. When the second assembly is at a first position and the connection mechanism is at a second position, the second assembly is located above the first assembly, the pushing part and the first locking part are far from the connection mechanism, and the fourth locking part locks the third locking part to restrict the relative movement between the driven element and the body.Type: ApplicationFiled: January 29, 2008Publication date: February 26, 2009Applicant: INVENTEC CORPORATIONInventor: Jin-Jen Lin
-
Patent number: 7468425Abstract: We have discovered p40, the shortest variant of a new human p53 homologue (p40/p51/p63/p73H). We have also found that it plays a role in cancer. Low level amplification of the p40 locus accompanied by RNA and protein overexpression was observed in primary lung cancers, and head and neck cancer cell lines. P40 protein overexpression in primary lung tumors was limited to squamous cell carcinoma, tumors known to harbor a high frequency of p53 mutations. Overexpression of p40 in Rat 1a cells led to an increase in soft agar growth and tumor size in mice. We searched for p40 binding proteins using the yeast two-hybrid system. P53 was the most common binding target of the 1.6×106 clones screened from a mouse embryonic library. Moreover, coexpression of p40 and p53 led to a decrease in p53 transcriptional activity. Our results support the notion that p40 plays an oncogenic role in human cancer.Type: GrantFiled: October 22, 2002Date of Patent: December 23, 2008Assignee: The Johns Hopkins UniversityInventors: David Sidransky, Jin Jen, Barry Trink, Edward A. Ratovitski
-
Publication number: 20080168518Abstract: In a method of reducing upstream ingress noise in cable data system, downstream management messages containing information about user group data uploading time and channel frequency are broadcasted by a headend of the cable data system. The broadcasted downstream management messages are monitored, so as to determine an upstream channel connection time schedule for the user groups. Each user group is connected to an upstream channel of the headend only at a data uploading time scheduled for that user group. As a result, ingress noise existed in the user group will be uploaded to the headend only when the user group is connected to the headend. Therefore, accumulation of upstream ingress noise at the headend is effectively reduced, and the headend network can maintain good signal quality to ensure best network connection.Type: ApplicationFiled: January 5, 2007Publication date: July 10, 2008Inventors: Jin-Jen Hsue, Wei-Chih Lu
-
Patent number: 7332590Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.Type: GrantFiled: August 16, 2002Date of Patent: February 19, 2008Assignees: The United States of America as Represented by the Department of Health and Human Services, Genzyme Corporation, The Johns Hopkins University of MedicineInventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
-
Publication number: 20070218511Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell, and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.Type: ApplicationFiled: August 14, 2006Publication date: September 20, 2007Inventors: Jin Jen, Gary Beaudry, Stephen Madden, Arthur Bertlesen, David Sidransky
-
Publication number: 20050136403Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.Type: ApplicationFiled: August 16, 2002Publication date: June 23, 2005Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
-
Publication number: 20040018538Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.Type: ApplicationFiled: June 24, 2003Publication date: January 29, 2004Applicant: Johns Hopkins UniversityInventors: Makiko Fliss, David Sidransky, Jin Jen, Kornelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
-
Patent number: 6605433Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.Type: GrantFiled: March 15, 2000Date of Patent: August 12, 2003Assignee: The Johns Hopkins UniversityInventors: Makiko Fliss, David Sidransky, Jin Jen, Komelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
-
Patent number: 6587350Abstract: An ejection mechanism for modular electronic elements is used for ejecting a modular electronic element housed in a housing chamber of an electronic device. The ejection mechanism is located in the housing chamber. By moving only one driving member, the latching relationship of the modular electronic element may be released and the modular electronic element may be ejected out of the housing chamber to facilitate replacement of various types of modular electronic elements.Type: GrantFiled: May 16, 2002Date of Patent: July 1, 2003Assignee: Inventec CorporationInventors: Jin Jen Lin, Sung Ming Song
-
Publication number: 20030113774Abstract: We have discovered p40, the shortest variant of a new human p53 homologue (p40/p51/p63/p73H). We have also found that it plays a role in cancer. Low level amplification of the p40 locus accompanied by RNA and protein overexpression was observed in primary lung cancers, and head and neck cancer cell lines. P40 protein overexpression in primary lung tumors was limited to squamous cell carcinoma, tumors known to harbor a high frequency of p53 mutations. Overexpression of p40 in Rat 1a cells led to an increase in soft agar growth and tumor size in mice. We searched for p40 binding proteins using the yeast two-hybrid system. P53 was the most common binding target of the 1.6×106 clones screened from a mouse embryonic library. Moreover, coexpression of p40 and p53 led to a decrease in p53 transcriptional activity. Our results support the notion that p40 plays an oncogenic role in human cancer.Type: ApplicationFiled: October 22, 2002Publication date: June 19, 2003Applicant: The Johns Hopkins UniversityInventors: David Sidransky, Jin Jen, Barry Trink, Edward A. Ratovitski